These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1469 related items for PubMed ID: 9828246
1. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. Tsai HM, Lian EC. N Engl J Med; 1998 Nov 26; 339(22):1585-94. PubMed ID: 9828246 [Abstract] [Full Text] [Related]
2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. N Engl J Med; 1998 Nov 26; 339(22):1578-84. PubMed ID: 9828245 [Abstract] [Full Text] [Related]
3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M, Lämmle B. Best Pract Res Clin Haematol; 2001 Jun 26; 14(2):437-54. PubMed ID: 11686108 [Abstract] [Full Text] [Related]
4. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M. Thromb Haemost; 1999 Nov 26; 82(5):1386-9. PubMed ID: 10595623 [Abstract] [Full Text] [Related]
9. von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Sahud MA, Claster S, Liu L, Ero M, Harris K, Furlan M. Br J Haematol; 2002 Mar 26; 116(4):909-11. PubMed ID: 11886400 [Abstract] [Full Text] [Related]
10. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Furlan M, Robles R, Morselli B, Sandoz P, Lämmle B. Thromb Haemost; 1999 Jan 26; 81(1):8-13. PubMed ID: 10348715 [Abstract] [Full Text] [Related]
11. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Tsai HM. J Mol Med (Berl); 2002 Oct 26; 80(10):639-47. PubMed ID: 12395148 [Abstract] [Full Text] [Related]
13. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Furlan M, Robles R, Solenthaler M, Lämmle B. Blood; 1998 Apr 15; 91(8):2839-46. PubMed ID: 9531594 [Abstract] [Full Text] [Related]
14. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura. Furlan M, Lämmle B. Semin Thromb Hemost; 2002 Apr 15; 28(2):167-72. PubMed ID: 11992240 [Abstract] [Full Text] [Related]
15. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M, Mikovic D, Karimi M, Giuffrida G, Laurenti L, Mannucci PM. Haematologica; 2008 Feb 15; 93(2):232-9. PubMed ID: 18223285 [Abstract] [Full Text] [Related]